Informações:
Falhas:
ID
16247
Descrição
Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00160901
Link
https://clinicaltrials.gov/show/NCT00160901
Palavras-chave
Versões (1)
- 07/07/2016 07/07/2016 -
Transferido a
7 de julho de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Cancer NCT00160901
Eligibility Breast Cancer NCT00160901
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00160901
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Indication Chemotherapy cycle Breast Carcinoma
Item
indication for chemotherapy for breast cancer for at least 3 cycles
boolean
C3146298 (UMLS CUI [1,1])
C1302181 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C1302181 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
Prior Chemotherapy
Item
prior chemotherapy within 12 months
boolean
C1514457 (UMLS CUI [1])
Herbal Drugs Supplement | Dietary Supplements | Pharmaceutical Preparations Supplemental | Pharmaceutical Preparations Alternative | Chemotherapy
Item
use of herbal or nutritional supplements or other complementary or alternative medications ≥ 7 days prior to start of chemotherapy and during the trial
boolean
C1360419 (UMLS CUI [1,1])
C2348609 (UMLS CUI [1,2])
C0242295 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C2348609 (UMLS CUI [3,2])
C0013227 (UMLS CUI [4,1])
C1523987 (UMLS CUI [4,2])
C0392920 (UMLS CUI [5])
C2348609 (UMLS CUI [1,2])
C0242295 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C2348609 (UMLS CUI [3,2])
C0013227 (UMLS CUI [4,1])
C1523987 (UMLS CUI [4,2])
C0392920 (UMLS CUI [5])
Hypersensitivity Investigational New Drug
Item
allergy to study medication
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
Selenium Intoxication
Item
selenium intoxication
boolean
C0036581 (UMLS CUI [1,1])
C0728899 (UMLS CUI [1,2])
C0728899 (UMLS CUI [1,2])
coumarin | Pharmaceutical Preparations Affecting Blood coagulation System
Item
current use of cumarins or other medication influencing the coagulation system
boolean
C0010206 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0005778 (UMLS CUI [2,3])
C0449913 (UMLS CUI [2,4])
C0013227 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0005778 (UMLS CUI [2,3])
C0449913 (UMLS CUI [2,4])
Edema | Decreased cardiac function | Renal Insufficiency
Item
edema in case of impaired cardial or renal function
boolean
C0013604 (UMLS CUI [1])
C0232166 (UMLS CUI [2])
C1565489 (UMLS CUI [3])
C0232166 (UMLS CUI [2])
C1565489 (UMLS CUI [3])
Other medical condition Severe
Item
other severe medical condition
boolean
C3843040 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Mental disorders | CNS disorder
Item
psychiatric or central neurological disorders
boolean
C0004936 (UMLS CUI [1])
C0007682 (UMLS CUI [2])
C0007682 (UMLS CUI [2])
Fluid intake Regular per day
Item
regular fluid intake < 2000 ml per day
boolean
C0429791 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0439505 (UMLS CUI [1,3])
C0205272 (UMLS CUI [1,2])
C0439505 (UMLS CUI [1,3])